New treatments and azathioprine in multiple sclerosis.
Palace
J
J
Rothwell
P
P
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D000068717:Glatiramer Acetate; D006801:Humans; D016899:Interferon-beta / Q000008:administration & dosage; D009103:Multiple Sclerosis / Q000628:therapy*; D010455:Peptides / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D018501:Antirheumatic Agents; D010455:Peptides; D000068717:Glatiramer Acetate; D016899:Interferon-beta; D001379:Azathioprine